Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2018 1
2019 2
2021 3
2022 6
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Pyoderma Gangrenosum after Cardiac Surgery.
Petrov A, Kappert U, Schmidt T, Matschke KE, Wilbring M. Petrov A, et al. Thorac Cardiovasc Surg. 2023 Jan;71(1):53-61. doi: 10.1055/s-0041-1735960. Epub 2021 Dec 11. Thorac Cardiovasc Surg. 2023. PMID: 34894635
Cardiac Surgery for Treatment of COVID-19-Associated Infectious Endocarditis.
Taghizadeh-Waghefi A, Petrov A, Wilbring M, Alexiou K, Kappert U, Matschke K, Tugtekin SM. Taghizadeh-Waghefi A, et al. Among authors: petrov a. Tex Heart Inst J. 2023 Mar 1;50(2):e227884. doi: 10.14503/THIJ-22-7884. Tex Heart Inst J. 2023. PMID: 36940421 Free PMC article. Review.
Mesenteric Ischemia after Cardiac Surgery.
Petrov A, Taghizadeh-Waghefi A, Hotz F, Georgi C, Matschke KE, Busch A, Wilbring M. Petrov A, et al. Thorac Cardiovasc Surg. 2024 May 3. doi: 10.1055/s-0044-1786183. Online ahead of print. Thorac Cardiovasc Surg. 2024. PMID: 38701840
Aortic Thrombosis following COVID-19: A Systematic Review.
Petrov A, De Glee Romera JP, Wilbring M, Alexiou K, Kappert U, Matschke KE, Tugtekin SM. Petrov A, et al. Thorac Cardiovasc Surg. 2022 Jun;70(4):323-332. doi: 10.1055/s-0041-1740554. Epub 2022 Feb 2. Thorac Cardiovasc Surg. 2022. PMID: 35108736
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group. Rubin DT, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798036 Clinical Trial.
21 results